CancerGuide Diagnostics, Inc. — Form D/A
CancerGuide Diagnostics, Inc. of DURHAM, NC, a company, filed a Form D amendment with the SEC on 2010-03-25. The offering totals $10.5M, of which $2.7M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2010-03-25
- Form: D/A
- Accession: 0001481448-10-000003
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $10.5M
- Amount sold: $2.7M
- Remaining: $7.7M
- Investors: 5
- Date of first sale: 2010-01-20
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-138168
Issuer
- Name: CancerGuide Diagnostics, Inc.
- CIK: 0001481448
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2006
- Address: 231 WINTERBERRY RIDGE DRIVE, DURHAM, NC, 27713
- Phone: (919) 215-5962
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| David King | Director | New York, NY |
| Garheng Kong | Director | Seattle, WA |
| MYLA LAI-GOLDMAN | Director | Durham, NC |
| Clay Thorp | Director | Durham, NC |
| William Haas | Executive Officer | Durham, NC |
| MYLA LAI-GOLDMAN | Executive Officer | Durham, NC |
| Judd Staples | Executive Officer | Durham, NC |
Other filings by this issuer (1)
More